{
    "ticker": "LIVN",
    "name": "LivaNova PLC",
    "description": "LivaNova PLC is a global medical technology company focused on developing innovative solutions for the treatment of cardiovascular and neuromodulation conditions. Established in 2015 through the merger of Sorin Group and Cyberonics, LivaNova is dedicated to improving the lives of patients by providing advanced therapies in cardiopulmonary and neurological care. The company offers a range of products, including heart-lung machines, ventricular assist devices, and neuromodulation therapies for epilepsy and depression. LivaNova\u2019s commitment to research and development enables it to continuously innovate and enhance patient care, supporting healthcare professionals with cutting-edge technologies and solutions. With a strong global presence, LivaNova operates in more than 100 countries, ensuring that patients worldwide have access to its life-saving therapies. The company is also focused on sustainable practices and ethical governance, striving to make a positive impact on the healthcare community and society as a whole.",
    "industry": [
        "Medical Technology",
        "Healthcare"
    ],
    "headquarters": "London, United Kingdom",
    "founded": "2015",
    "website": "https://www.livanova.com",
    "ceo": "Damien McDonald",
    "social_media": {
        "twitter": "https://twitter.com/LivaNovaPLC",
        "linkedin": "https://www.linkedin.com/company/livanova/"
    },
    "investor_relations": "https://investors.livanova.com",
    "key_executives": [
        {
            "name": "Damien McDonald",
            "position": "CEO"
        },
        {
            "name": "Peter A. W. H. H. D. de Vries",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Cardiovascular",
            "products": [
                "Heart-Lung Machines",
                "Ventricular Assist Devices"
            ]
        },
        {
            "category": "Neuromodulation",
            "products": [
                "Vagus Nerve Stimulation Devices",
                "Neurostimulators"
            ]
        }
    ],
    "seo": {
        "meta_title": "LivaNova PLC | Innovative Medical Technologies",
        "meta_description": "Explore LivaNova PLC, a leader in medical technology focused on cardiovascular and neuromodulation therapies. Discover our innovative solutions and commitment to patient care.",
        "keywords": [
            "LivaNova",
            "Medical Technology",
            "Cardiovascular",
            "Neuromodulation",
            "Healthcare",
            "Heart-Lung Machines",
            "Vagus Nerve Stimulation"
        ]
    },
    "faq": [
        {
            "question": "What does LivaNova specialize in?",
            "answer": "LivaNova specializes in medical technologies for cardiovascular and neuromodulation treatments."
        },
        {
            "question": "Who is the CEO of LivaNova?",
            "answer": "Damien McDonald is the CEO of LivaNova PLC."
        },
        {
            "question": "Where is LivaNova headquartered?",
            "answer": "LivaNova is headquartered in London, United Kingdom."
        },
        {
            "question": "What are LivaNova's main products?",
            "answer": "LivaNova's main products include heart-lung machines, ventricular assist devices, and vagus nerve stimulation devices."
        },
        {
            "question": "When was LivaNova founded?",
            "answer": "LivaNova was founded in 2015."
        }
    ],
    "competitors": [
        "MDT",
        "SYK",
        "ZBH"
    ],
    "related_stocks": [
        "ABBV",
        "JNJ",
        "PFE",
        "BMY"
    ]
}